Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20,880 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir in adults with virologically suppressed HIV (STRATEGY-PI): 48 week results of a randomised, open-label, phase 3b, non-inferiority trial.
Arribas JR, Pialoux G, Gathe J, Di Perri G, Reynes J, Tebas P, Nguyen T, Ebrahimi R, White K, Piontkowsky D. Arribas JR, et al. Among authors: nguyen t. Lancet Infect Dis. 2014 Jul;14(7):581-9. doi: 10.1016/S1473-3099(14)70782-0. Epub 2014 Jun 5. Lancet Infect Dis. 2014. PMID: 24908551 Clinical Trial.
Switching to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of non-nucleoside reverse transcriptase inhibitor with emtricitabine and tenofovir in virologically suppressed adults with HIV (STRATEGY-NNRTI): 48 week results of a randomised, open-label, phase 3b non-inferiority trial.
Pozniak A, Markowitz M, Mills A, Stellbrink HJ, Antela A, Domingo P, Girard PM, Henry K, Nguyen T, Piontkowsky D, Garner W, White K, Guyer B. Pozniak A, et al. Among authors: nguyen t. Lancet Infect Dis. 2014 Jul;14(7):590-9. doi: 10.1016/S1473-3099(14)70796-0. Epub 2014 Jun 5. Lancet Infect Dis. 2014. PMID: 24908550 Clinical Trial.
Patient-Reported Symptoms over 48 Weeks in a Randomized, Open-Label, Phase 3b Non-inferiority Trial of Adults with HIV Switching to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir DF Versus Continuation of Ritonavir-Boosted Protease Inhibitor with Emtricitabine and Tenofovir DF.
Gathe J, Arribas JR, Van Lunzen J, Garner W, Speck RM, Bender R, Shreay S, Nguyen T. Gathe J, et al. Among authors: nguyen t. Patient. 2015 Oct;8(5):445-54. doi: 10.1007/s40271-015-0137-9. Patient. 2015. PMID: 26286337 Free PMC article. Clinical Trial.
Baseline antiretroviral resistance mutations and treatment-emergent resistance in HIV-1 RNA-suppressed patients switching to EVG/COBI/FTC/TDF or continuing on their PI-, NNRTI-, or RAL-based regimen.
Andreatta K, Kulkarni R, Abram ME, Nguyen T, Cao H, Miller MD, White KL. Andreatta K, et al. Among authors: nguyen t. J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):519-26. doi: 10.1097/QAI.0000000000000503. J Acquir Immune Defic Syndr. 2015. PMID: 25559592
Simplification to single-tablet regimen of elvitegravir, cobicistat, emtricitabine, tenofovir DF from multi-tablet ritonavir-boosted protease inhibitor plus coformulated emtricitabine and tenofovir DF regimens: week 96 results of STRATEGY-PI.
Arribas JR, DeJesus E, van Lunzen J, Zurawski C, Doroana M, Towner W, Lazzarin A, Nelson M, McColl D, Andreatta K, Swamy R, Szwarcberg J, Nguyen T. Arribas JR, et al. Among authors: nguyen t. HIV Clin Trials. 2017 May;18(3):118-125. doi: 10.1080/15284336.2017.1330440. Epub 2017 May 30. HIV Clin Trials. 2017. PMID: 28555519 Clinical Trial.
Patient-Reported Symptoms Over 48 Weeks in a Randomized, Open-Label, Phase IIIb Non-Inferiority Trial of Adults with HIV Switching to Co-Formulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir DF versus Continuation of Non-Nucleoside Reverse Transcriptase Inhibitor with Emtricitabine and Tenofovir DF.
Mills A, Garner W, Pozniak A, Berenguer J, Speck RM, Bender R, Nguyen T. Mills A, et al. Among authors: nguyen t. Patient. 2015 Aug;8(4):359-71. doi: 10.1007/s40271-015-0129-9. Patient. 2015. PMID: 26045359 Free PMC article. Clinical Trial.
Microresonator photonic wire bond integration for Kerr-microcomb generation.
Takabayashi AY, Pavlov N, Rosborough V, Hoffman G, Kanger L, Koushyar FM, Huffman T, Nelson M, Turner C, Johansson L, Musolf J, Garrett H, Liu T, Morrison G, Chembo Y, Mattis B, Nguyen TA, Van Camp M, Turner SE, Karpov M, Jost J, Burkley Z. Takabayashi AY, et al. Among authors: nguyen ta. Sci Rep. 2024 Nov 23;14(1):29054. doi: 10.1038/s41598-024-79945-4. Sci Rep. 2024. PMID: 39580548 Free article.
20,880 results
You have reached the last available page of results. Please see the User Guide for more information.